106 related articles for article (PubMed ID: 24606744)
1. [Inhibitory effect of suberoylanilide hydroxamic acid on angiogenesis and its molecular mechanism].
Wang N; Chen L; Zhang L; Jiang R; Chen L; Shen Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Mar; 30(3):266-9, 273. PubMed ID: 24606744
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro.
Jin G; Bausch D; Knightly T; Liu Z; Li Y; Liu B; Lu J; Chong W; Velmahos GC; Alam HB
Surgery; 2011 Sep; 150(3):429-35. PubMed ID: 21878227
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA).
Futakuchi A; Inoue T; Fujimoto T; Kuroda U; Inoue-Mochita M; Takahashi E; Ohira S; Tanihara H
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2421-2429. PubMed ID: 28448670
[TBL] [Abstract][Full Text] [Related]
4. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of von Willebrand factor-cleaving protease on angiogenesis].
Jin C; Wang S; Zhao Y; Jin S; Li H
Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):602-6. PubMed ID: 26304087
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure.
Qiu X; Rong X; Yang J; Lu Y
BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells.
Cheng HT; Hung WC
Oncol Rep; 2013 Mar; 29(3):1238-44. PubMed ID: 23242251
[TBL] [Abstract][Full Text] [Related]
9. Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis.
Hakami NY; Dusting GJ; Peshavariya HM
J Cell Mol Med; 2016 Oct; 20(10):1932-44. PubMed ID: 27297729
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of proliferation, sprouting, tube formation and Tie2 signaling of lymphatic endothelial cells by the histone deacetylase inhibitor SAHA.
Cheng HT; Hung WC
Oncol Rep; 2013 Aug; 30(2):961-7. PubMed ID: 23754070
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
12. Enhanced anticancer efficacy of histone deacetyl inhibitor, suberoylanilide hydroxamic acid, in combination with a phosphodiesterase inhibitor, pentoxifylline, in human cancer cell lines and in-vivo tumor xenografts.
Nidhyanandan S; Thippeswamy BS; Chandrasekhar KB; Reddy ND; Kulkarni NM; Karthikeyan K; Khan FR; Raghul J; Vijaykanth G; Narayanan S
Anticancer Drugs; 2017 Oct; 28(9):1002-1017. PubMed ID: 28727579
[TBL] [Abstract][Full Text] [Related]
13. The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.
Duncan HF; Smith AJ; Fleming GJ; Partridge NC; Shimizu E; Moran GP; Cooper PR
J Cell Physiol; 2016 Apr; 231(4):798-816. PubMed ID: 26264761
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.
Deroanne CF; Bonjean K; Servotte S; Devy L; Colige A; Clausse N; Blacher S; Verdin E; Foidart JM; Nusgens BV; Castronovo V
Oncogene; 2002 Jan; 21(3):427-36. PubMed ID: 11821955
[TBL] [Abstract][Full Text] [Related]
15. Trans-3,4,5,4'-tetramethoxystilbene, a resveratrol analog, potently inhibits angiogenesis in vitro and in vivo.
Chen LK; Qiang PF; Xu QP; Zhao YH; Dai F; Zhang L
Acta Pharmacol Sin; 2013 Sep; 34(9):1174-82. PubMed ID: 23770989
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
[TBL] [Abstract][Full Text] [Related]
17. CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo.
Chikaraishi Y; Shimazawa M; Yokota K; Yoshino K; Hara H
Curr Neurovasc Res; 2009 Aug; 6(3):140-7. PubMed ID: 19534723
[TBL] [Abstract][Full Text] [Related]
18. Orally Administered Mucolytic Drug l-Carbocisteine Inhibits Angiogenesis and Tumor Growth in Mice.
Shinya T; Yokota T; Nakayama S; Oki S; Mutoh J; Takahashi S; Sato K
J Pharmacol Exp Ther; 2015 Sep; 354(3):269-78. PubMed ID: 26126534
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
20. Suberoylanilide hydroxamic acid suppresses inflammation-induced neovascularization.
Zhou H; Jiang S; Chen J; Su SB
Can J Physiol Pharmacol; 2014 Oct; 92(10):879-85. PubMed ID: 25272091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
